Perspectives
Platelet-derived Growth Factor Structure, Function, and Roles in Normal and Transformed Cells Polypeptide growth factors regulate the proliferation of cells in culture alone or in concert with other mitogens by inducing DNA synthesis and cell division in specific target cells. The mechanisms of action and the in vivo functions of these polypeptide growth factors are not known. It seems likely that growth factors have some role in cell development, differentiation, and tissue repair. Of the known growth factors, epidermal growth factor (EGF),' the platelet-derived growth factor (PDGF), and nerve growth factor are best defined. Each interacts with target cells through specific cell-surface receptors, leading to DNA synthesis, cell proliferation, and morphological and biochemical changes which resemble those characteristic of cells transformed by acute retroviruses (1) (2) (3) (4) (5) . Malignant transformed cells also synthesize and secrete polypeptide growth factors which may stimulate autonomous cellular proliferation by an autocrine mechanism (6) . In this article, we will summarize results of recent studies on the structure and biology of one well-characterized growth factor, PDGF, and attempt to relate how PDGF and perhaps PDGF-like molecules may play important roles in malignant transformation and cell growth of virus-transformed cells.
Origins ofPDGF
Platelets do not bind to intact endothelium. PDGF is contained in alpha granules of platelets and is released only during blood clotting or when platelets adhere at sites of blood vessel injury. Secretion of platelet contents can be initiated by exposure of platelets to foreign surfaces such as subendothelial basement membrane or collagen (7) (8) (9) . PDGF may serve to promote wound healing since it is the most potent mitogen in serum for cells of mesenchymal origins, including fibroblasts, glial cells, and smooth muscle cells (10, 11) . Cells ordinarily are Receivedfor publication I May 1984. 1 . Abbreviations used in this paper: EGF, epidermal growth factor, PGDF, platelet-derived growth factor, SSV, simian sarcoma virus. Thomas Physical/chemical characterizations ofPDGF PDGF was difficult to purify because of the very small quantities in platelets and because ofcontaminating proteolytic activity. Early purifications (12) (13) (14) succeeded in defining the properties of PDGF which were later exploited for larger scale purifications of milligram quantities of PDGF (15) (16) (17) (18) (19) . PDGF is a highly basic (pI -10.2) glycoprotein which has been separated into two equally active protein fractions differing only in covalently bound carbohydrate content. PDGF I is -31 kD and contains -7% carbohydrate, whereas PDGF II is -28 kD and contains -4% carbohydrate; PDGFs I and II have essentially equal mitogenic activity, amino acid composition, and immunological reactivity (15, 16, 20, 21) . Both PDGF I and II appear to have 18 half-cystine residues all in disulfide linkage. Reduction of these disulfide linkages abolishes biological (mitogenic) activity and separates PDGF into larger A chains (PDGF I, -17 kD; PDGF II, -15 kD) and smaller B chains (PDGFs I and II, -14 kD) (15, 16) .
Anti-PDGF antisera have been used to measure PDGF levels in biological fluids by radioimmunoassay (21 (29) . The physiological significance of receptor downregulation is not established, but down-regulation may serve as a mechanism to limit additional cellular proliferation that might result from prolonged exposure to growth factors.
An immediate consequence of growth factor binding to specific cell-surface receptors is protein phosphorylation. Tyrosine phosphorylation of EGF receptors can be demonstrated within 1-2 min of EGF addition to target cells (30, 31). The EGF cell surface receptor has been purified and shown to be a tyrosine-specific protein kinase; the EGF receptor-kinase itself can serve as a substrate for the EGF protein tyrosine kinase activity, i.e., autophosphorylation (32, 33) . PDGF likewise stimulates tyrosine-specific protein kinase activity in membranes of fibroblasts (34, 35) , phosphorylating a 180 kD protein thought to be the PDGF receptor. Recently, the receptor protein for PDGF has been purified and found to be a 180 kD glycoprotein with intrinsic and PDGF-stimulated protein tyrosine kinase activity (36) . The PDGF receptor/ kinase can also serve as substrate for its own kinase activity; the function of autophosphorylation of PDGF and other receptor proteins has yet to be elucidated but may be related to the regulation of receptor activity or turnover or may be directly responsible for initiating the biochemical events that lead to cell division.
Tyrosine kinase activity in viral transformed cells
The tyrosine-specific protein kinase activity of the PDGF receptor protein suggests a close parallel to biological activities observed in retrovirus transformed cells. The transforming protein of the acute transforming Rous sarcoma virus (37), pp60V-, is a tyrosine-specific protein kinase and is responsible for the initiation and maintenance of transformation in Rous sarcoma virus infected cells. The pp60v-sIc protein kinase activity is the product of the viral oncogene v-src and is believed to be active in transformed cells because Rous sarcoma virus transformed cells have increased levels of phosphotyrosine residues in proteins compared with the levels in nontransformed cells (37) (38) (39) (40) (41) (42) . The association of viral oncogene-protein tyrosine kinase activity and growth factor receptor-protein tyrosine kinase activity has suggested that the activation of these kinases may initiate a common cascade of growth regulatory pathways in transformed cells and in cells stimulated by growth factors that lead to cellular proliferation.
The normal cellular genomic homologue of v-src (the proto-oncogene, c-src) has been found in normal eukaryotic cell DNA (43) (44) (45) (46) (47) ; this finding suggested that the viral oncogene was acquired from normal cellular chromosomal DNA by genetic recombination, a suggestion confirmed in later studies. Phosphotyrosine normally is present in eukaryotic cellular proteins in relatively small amounts, accounting for -0.01-0.03% of total amino acids in proteins (48) . Attempts have been made to identify the naturally occurring protein substrates for the tyrosine kinase activity associated with Rous sarcoma virus transformation and growth factor stimulation of cells. Whereas a number of common substrates for protein tyrosine kinases have been identified (49, 50) , the true physiological role of tyrosine kinases and autophosphorylation in growth factor-stimulated, viral-transformed cells has yet to be established.
Early activities ofPDGF-stimulated cells PDGF induces pleiotrophic effects when added to cultured fibroblasts or glial cells that contain PDGF receptors. Activities stimulated in target cells include the enhancement of glycolysis (51) , the stimulation of amino acid transport and protein synthesis (52) , the induction of early changes in phosphatidyl inositol and arachidonic acid metabolism (53), the stimulation of prostaglandin synthesis (54, 55), the stimulation of polysome formation (56) , and the reorganization of actin filaments (as reviewed, 2, 3, 5; 57, 58). Of particular interest is the similarity of stimulated activities of cells exposed to growth factors and of cells transformed by viruses. Cells Chemotactic activity: possible normal role of PDGF in wound healing PDGF is generally believed to be the principle mitogen that stimulates cell division where vessel integrity has been compromised and platelet activation has occurred. PDGF has a second property, however, which suggests further that a normal role of PDGF may be to act as a mediator of inflammation and repair; PDGF is a potent chemotactic protein for inflammatory cells. Maximum neutrophil chemotaxis occurs at PDGF concentrations of 1-5 ng/ml, whereas PDGF-stimulated monocyte chemotaxis occurs maximally at a concentration of 20 ng/ml (68) . These concentrations of PDGF are well below those found in human serum (50 ng/ml) (21) . At somewhat higher concentrations (20-40 ng/ml), PDGF activates human neutrophils, initiating superoxide synthesis and release, specific neutrophil granule release, and neutrophil aggregation (Tseng, D., T. F. Deuel, J. Huang, L. Boxer, R. Senior, and R. Baehner, unpublished data). Smooth muscle cells and fibroblasts are similarly strongly attracted to low concentrations of PDGF (10-20 ng/ml) (69) (70) (71) , suggesting these cells may migrate to injured sites where subsequent mitogenic stimulation furthers repair processes. PDGF-stimulated fibroblasts synthesize collagenase; PDGF at 20 ng/ml increases the synthesis and release of collagenase from cultured human skin fibroblasts approximately sevenfold (Bauer, E., J. S. Huang, T. F. Deuel, J. Altman, and J. Cooper, unpublished data), perhaps serving a vital function in hydrolyzing damaged collagen before wound remodeling and repair. The structural determinant of PDGF that mediates chemotaxis may be different from the one that mediates mitogenesis (72) .
The presence of inflammatory cells and fibroblasts in wounds (and smooth muscle cells in wounds of blood vessels) may be correlated with the PDGF concentrations achieved by platelet release. In the guinea pig, fibrin formation is first found in the healing wound; neutrophil influx is then followed by macrophage influx and then by fibroblast migration (73) . The temporal migration of these cells into wounds thus correlates reasonably well with concentrations of PDGF required for maximum chemotaxis. At the higher concentrations of PDGF believed to be present more proximally in wounded areas into which cell migration has occurred, neutrophil activation, fibroblast release of collagenase, and cell division follow. PDGF thus may play a pivotal role in wound healing (Fig. 1) Direct support for such relatedness was recently obtained when the amino acid sequence analysis of PDGF resulted in the remarkable finding of >90% homology between the amino acid sequence of the larger chain (A chain) of PDGF and the predicted amino acid sequence of p28v, the putative transforming protein of the simian sarcoma virus (SSV) (75, 76) (Fig. 2) . Subsequent sequence analysis coupled with the isolation and sequencing of human c-sis genomic DNA (77) established the nucleotide sequences of five regions of the human c-sis gene that were homologous to sequences of the transforming region (v-sis) of SSV. Analysis of the A chain of PDGF showed identity of amino acid sequences predicted for the c-sis gene product through 109 residues. Thus, the human c-sis gene almost certainly encodes a polypeptide precursor of the A chain of PDGF; a partial sequence of the smaller chain (B chain) is 60% homologous to the A chain and cannot be encoded by that part of the c-sis genomic DNA so far sequenced, but it may lie 5' to the 5 20 kD, consistent with the proteolytically processed product of p28v" (78) . Thus, the protein in SSV- Oncogenes may be derived from normal cellular genomic sequences encoding for growth factor receptors and produce transformation through the unregulated expression of growth factor-receptor activity. The role of the PDGF receptor protein needs to be established to indicate whether the receptor protein contains the information required for cellular proliferation and/or malignant transformation. The role of the receptor protein tyrosine kinase activity must also be determined in order to understand whether it is required for cell proliferation/ transformation or is important in regulation of receptor endocytosis or agonist binding. That the PDGF receptor also has the potential to function as an oncogene product (transforming protein) has been established with near certainty with the recent recognition that six peptides derived from the human EGF receptor protein match closely the deduced amino acid sequence of the v-erb-B transforming protein of the avian myeloblastosis virus (100). Thus, the receptor protein for EGF and presumably for PDGF appears to have the potential to stimulate both cellular proliferation and transformation.
How p28v415 initiates transformation also must be understood. The apparent failure of some SSV-transformed cells to secrete transforming protein implies strongly that malignant transformation in SSV-transformed cells can be mediated through the intracellular recognition of p28v4S, as opposed to growth stimulation by the autocrine secretion of transforming protein. A possible mechanism whereby this might occur is when newly synthesized PDGF receptor protein with the PDGF recognition site within the endoplasmic reticulum interacts with p28". In this circumstance, activated receptor protein tyrosine kinase activity would remain exposed to the cytoplasmic surface and perhaps initiate a cascade of reactions to initiate the inappropriate cell division responsible for transformation.
The role of growth factors in normal cellular physiology and in malignant transformation remains elusive, but provocative results now suggest the relationships soon will be better understood. The results are likely to suggest complex mechanisms of tumor formation; carcinogenesis appears to involve multiple steps (101) , and multiple cellular oncogenes seem to be transcriptionally active in tumors (102) .
